Sex‐based differences in early and late uveal melanoma‐related mortality

BACKGROUND: It is debated if there are sex‐based differences in survival for patients with uveal melanoma. Previous observations of higher mortality for men in studies with <10‐year follow‐up have not been replicated in studies with longer follow‐up. It is therefore hypothesized that women have a worse survival in later periods. METHODS: All patients diagnosed with primary uveal melanoma in Sweden between 1980 and 2017 were included (n = 2032). Survival differences between men and women in early (<10 years from diagnosis) and late (≥10 years) periods were analyzed. RESULTS: At baseline, there were no significant differences in mean patient age, tumor thickness, diameter, ciliary body involvement, primary treatment modality, or in American Joint Committee on Cancer (AJCC) T‐category between men and women. In total, 764 patients (425 women and 339 men) survived and were followed ≥10 years. In this group, men were significantly younger, but there were no differences in baseline tumor thickness, diameter, ciliary body involvement, primary treatment, or AJCC T‐category. In competing risk analysis, women had higher incidence of uveal melanoma‐related mortality in the late period (p = 0.036). In univariate Cox regression, male (HR 1.2, p = 0.049) and female sex (HR 1.8, p = 0.034) were significant predictors of uveal melanoma‐related mortality in the early and late periods, respectively. CONCLUSION: Women with uveal melanoma have better survival in the first decade after diagnosis. Thereafter, female survivors are significantly older than men and have a higher incidence of uveal melanoma‐related mortality.